Teva Pharmaceutical Industries (TEVA) Financials
TEVA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 43.5 billion | 35.4 billion |
2023-09-30 | 42.1 billion | 34.6 billion |
2023-06-30 | 43.1 billion | 35.4 billion |
2023-03-31 | 43.5 billion | 34.8 billion |
TEVA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 1.1 billion | 28.0 million |
2023-09-30 | -144.0 million | 31.0 million |
2023-06-30 | 205.0 million | 30.0 million |
2023-03-31 | -284.0 million | 32.0 million |
TEVA Net Income
No data available :(
TEVA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 3.2 billion | - | 320.0 million |
2023-09-30 | 2.2 billion | - | 324.0 million |
2023-06-30 | 2.7 billion | - | 338.0 million |
2023-03-31 | 2.1 billion | - | 345.0 million |
TEVA Shares Outstanding
TEVA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 119.0 million | 227.0 million | 292.0 million | 610.0 million |
2023-09-30 | 149.0 million | 253.0 million | 268.0 million | 576.0 million |
2023-06-30 | 119.0 million | 240.0 million | 307.0 million | 603.0 million |
2023-03-31 | 139.0 million | 234.0 million | 296.0 million | 546.0 million |
TEVA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 4.5 billion | 2.0 billion |
2023-09-30 | 3.9 billion | 2.0 billion |
2023-06-30 | 3.9 billion | 2.1 billion |
2023-03-31 | 3.7 billion | 2.1 billion |
TEVA
Price: $14.06
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.50 USD
P/E Ratio: -24.76
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 6.4 million
Ebitda: -12.5 billionMarket Capitalization: 15.9 billion
Average Dividend Frequency: 4